American Stock Exchange Lists Common Stock of Hana Biosciences Incorporated
22 Settembre 2005 - 7:45PM
PR Newswire (US)
NEW YORK, Sept. 22 /PRNewswire/ -- The American Stock Exchange(R)
(Amex(R)) today listed the common stock of Hana Biosciences
Incorporated, under the ticker symbol HBX. Hana Biosciences, Inc.
is a South San Francisco-based biopharmaceutical company that
acquires, develops, and commercializes products to advance cancer
care. "The American Stock Exchange is proud to welcome Hana
Biosciences into our expanding group of biotechnology firms," said
John McGonegal, senior vice president of the Amex Equities Group.
"We look forward to working with Hana Biosciences to increase its
profile among investors and assist its efforts to grow and thrive
in today's challenging marketplace." Hana Biosciences Inc has
selected Cohen Specialists LLC as its specialist. For further
information on HBX and other Amex-listed companies, please visit
http://www.amex.com/. The American Stock Exchange(R) (Amex(R)) is
the only primary exchange that offers trading across a full range
of equities, options and exchange traded funds (ETFs), including
structured products and HOLDRS(SM). In addition to its role as a
national equities market, the Amex is the pioneer of the ETF,
responsible for bringing the first domestic product to market in
1993. Leading the industry in ETF listings, the Amex lists 168 ETFs
to date. The Amex is also one of the largest options exchanges in
the U.S., trading options on broad-based and sector indexes as well
as domestic and foreign stocks. For more information, please visit
http://www.amex.com/. DATASOURCE: American Stock Exchange CONTACT:
Javier E. David, American Stock Exchange, +1-212-306-1440, Web
site: http://www.amex.com/
Copyright